Manufacturing

Articles

SGS’s new Antwerp, Belgium, clinical research site will house both clinical trial patients and good manufacturing practice drug manufacturing, and its Glasgow, UK, biosafety testing site now has increased testing capacity.

SGS Opens New Clinical Research Site in Belgium and Expands Biosafety Testing Capacity in UK

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

A new GMP facility in Raleigh, NC, and a starting materials facility in Paris, France, give Cellectis end-to-end, in-house manufacturing capacity for its UCART product candidates.  

Cellectis Opens GMP Manufacturing Facility

Smiths Detection has confirmed that the Bioflash air sampler can detect Beta, Gamma, Kappa, Delta, and Delta plus variants.

Smiths Detection Confirms BioFlash Detects Multiple Airborne SARS-CoV-2 Variants

Conventional and robotic automation inside closed systems reduces risk. 

Automating Aseptic Manufacturing

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, answers some commonly asked questions about aseptic processing.

The Basics of Aseptic Processing

NewAge Industries has completed a plant expansion that added new cleanrooms to its headquarters in Southampton, Pa.

NewAge Industries Completes Plant Expansion

Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.

Lonza to Expand Capabilities at Manufacturing Sites in Switzerland

CPC’s MicroCNX Series Connectors provide an alternative to tube welding at small tubing sizes.

New Sterile Connectors for Small-Bore Tubing Offer an Alternative to Welding

James P. Agalloco is the president of Agalloco & Associates, P.O. Box 899, Belle Mead, NJ 08502, tel. 908.874.7558, jagalloco@aol.com. He is also a member of Pharmaceutical Technology’s editorial advisory board.

Microbial experts should employ proactive practices on the manufacturing floor, rather than relying on testing.

Moving Out of the Lab to Optimize Microbial Control

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Aseptic/Sterile Processing